USA |NASDAQ |USD |ADR
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 15, 2022 | Jun 2022 | $-0.29 | - | $-0.21 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 15, 2022 | Jun 2022 | $0.00 | - | $0.00 |
Essa Pharma Inc's next earnings date is Monday, Aug 15, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 4 | $-0.29 | $-0.38 | $-0.24 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Sep 2022 | 4 | $-1.07 | $-1.33 | $-0.92 |
| Sep 2023 | 4 | $-1.33 | $-2.11 | $-0.98 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 0 / 0 | $-0.29 | $-0.26 | $-0.26 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Sep 2022 | 0 / 0 | $-1.07 | $-1.03 | $-1.04 |
| Sep 2023 | 0 / 0 | $-1.33 | $-1.01 | $-1.04 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 4 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Sep 2022 | 4 | $0.00 | $0.00 | $0.00 |
| Sep 2023 | 4 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 4, 2022 | Mar 2022 | $-0.25 | - | - |
| Feb 3, 2022 | Dec 2021 | $-0.23 | $-0.21 | 8.70% |
| Nov 18, 2021 | Sep 2021 | $-0.25 | $-0.20 | 19.68% |
| Aug 16, 2021 | Jun 2021 | $-0.28 | $-0.21 | 25.87% |
| May 6, 2021 | Mar 2021 | $-0.21 | $-0.36 | -70.12% |
| Feb 11, 2021 | Dec 2020 | $-0.17 | $-0.20 | -20.80% |
| Dec 15, 2020 | Sep 2020 | $-0.20 | $-0.17 | 15.30% |
| Aug 6, 2020 | Jun 2020 | $-0.36 | $-0.24 | 33.44% |
| May 7, 2020 | Mar 2020 | $-0.22 | $-0.45 | -105.20% |
| Feb 13, 2020 | Dec 2019 | $-0.18 | $-0.22 | -22.63% |
| Dec 19, 2019 | Sep 2019 | $-0.17 | $-0.23 | -32.13% |
| Aug 14, 2019 | Jun 2019 | $-0.54 | $-0.52 | 4.29% |
| May 10, 2019 | Mar 2019 | $-0.44 | $-0.54 | -23.36% |
| Feb 7, 2019 | Dec 2018 | - | $-0.43 | - |
| Dec 13, 2018 | Sep 2018 | $-0.43 | $-0.40 | 7.29% |
| Aug 14, 2018 | Jun 2018 | $-0.74 | $-0.50 | 32.34% |
| May 14, 2018 | Mar 2018 | $-0.40 | $-0.83 | -104.75% |
| Feb 13, 2018 | Dec 2017 | - | $-1.40 | - |
| Dec 12, 2017 | Sep 2017 | $-3.64 | $-1.40 | 61.53% |
| Aug 15, 2017 | Jun 2017 | $-3.53 | $-3.16 | 10.35% |
| May 15, 2017 | Mar 2017 | $-2.20 | $-5.21 | -136.74% |
| Feb 13, 2017 | Dec 2016 | - | $0.92 | - |
| Dec 14, 2016 | Sep 2016 | - | $-3.15 | - |
| Aug 12, 2016 | Jun 2016 | - | $-2.66 | - |
| May 13, 2016 | Mar 2016 | - | $-0.78 | - |
| Feb 12, 2016 | Dec 2015 | $-2.81 | $-2.30 | 18.09% |
| Dec 14, 2015 | Sep 2015 | $-0.07 | $0.08 | 214.29% |
| Aug 17, 2015 | Jun 2015 | $-0.13 | $-0.26 | -100.00% |
| May 28, 2015 | Mar 2015 | $-0.22 | $-0.20 | 9.09% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 18, 2021 | Sep 2021 | $-1.05 | $-0.97 | - |
| Dec 15, 2020 | Sep 2020 | - | $-1.08 | - |
| Dec 19, 2019 | Sep 2019 | - | $-1.72 | - |
| Dec 13, 2018 | Sep 2018 | - | $-3.13 | - |
| Dec 12, 2017 | Sep 2017 | - | $-8.85 | - |
| Dec 14, 2016 | Sep 2016 | - | $-8.89 | - |
| Dec 14, 2015 | Sep 2015 | - | $-0.38 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 4, 2022 | Mar 2022 | $0.00 | - | - |
| Feb 3, 2022 | Dec 2021 | $0.00 | $0.00 | - |
| Nov 18, 2021 | Sep 2021 | $0.00 | $0.00 | - |
| Aug 16, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 6, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Feb 11, 2021 | Dec 2020 | - | $0.00 | - |
| Dec 15, 2020 | Sep 2020 | - | $0.00 | - |
| Aug 6, 2020 | Jun 2020 | - | $0.00 | - |
| May 7, 2020 | Mar 2020 | - | $0.00 | - |
| Feb 13, 2020 | Dec 2019 | - | $0.00 | - |
| Dec 19, 2019 | Sep 2019 | - | $0.00 | - |
| Aug 14, 2019 | Jun 2019 | - | $0.00 | - |
| May 10, 2019 | Mar 2019 | - | $0.00 | - |
| Feb 7, 2019 | Dec 2018 | - | $0.00 | - |
| Dec 13, 2018 | Sep 2018 | - | $0.00 | - |
| Aug 14, 2018 | Jun 2018 | - | $0.00 | - |
| May 14, 2018 | Mar 2018 | - | $0.00 | - |
| Feb 13, 2018 | Dec 2017 | - | $0.00 | - |
| Dec 12, 2017 | Sep 2017 | - | $0.00 | - |
| Aug 15, 2017 | Jun 2017 | - | $0.00 | - |
| May 15, 2017 | Mar 2017 | - | $0.00 | - |
| Feb 13, 2017 | Dec 2016 | - | $0.00 | - |
| Dec 14, 2016 | Sep 2016 | - | $0.00 | - |
| Aug 12, 2016 | Jun 2016 | - | $0.00 | - |
| May 13, 2016 | Mar 2016 | - | $0.00 | - |
| Feb 12, 2016 | Dec 2015 | - | $0.00 | - |
| Dec 14, 2015 | Sep 2015 | - | $0.00 | - |
| Aug 17, 2015 | Jun 2015 | - | $0.00 | - |
| May 28, 2015 | Mar 2015 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 18, 2021 | Sep 2021 | $0.00 | $0.00 | - |
| Dec 15, 2020 | Sep 2020 | - | $0.00 | - |
| Dec 19, 2019 | Sep 2019 | - | $0.00 | - |
| Dec 13, 2018 | Sep 2018 | - | $0.00 | - |
| Dec 12, 2017 | Sep 2017 | - | $0.00 | - |
| Dec 14, 2016 | Sep 2016 | - | $0.00 | - |
| Dec 14, 2015 | Sep 2015 | - | $0.00 | - |
EPIX's next earnings date is Monday, Aug 15, 2022 for the fiscal quarter ending Jun 30, 2022.
According to analysts, the average EPS estimation for Essa Pharma Inc's next quarterly earnings is $-0.29, with a low EPS estimation of $-0.38, and a high estimation of $-0.24.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.29, the last 2 month trend is $-0.26, and the 3 month trend is $-0.26.
Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Essa Pharma Inc's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.
Essa Pharma Inc's previous annual earnings date was Nov 18, 2021 for its fiscal year ended Sep 30, 2021.
EPIX's earnings per share (EPS) was $-0.97, beating the consensus analysts forecast of $-1.05 by -7.65% , and higher than the previous year's EPS (Sep 2020) by -10.28%.
Revenues were $0.00.
The company reported a net income of $-36.81M.
Essa Pharma Inc reported a free cash flow of $-25.42M for its fiscal year, compared to $-16.98M a year ago.
The company ended the fiscal year with $330.97K in total debt, an increase of 460.07% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
